Viewing Study NCT00937560


Ignite Creation Date: 2025-12-25 @ 2:09 AM
Ignite Modification Date: 2026-03-07 @ 8:01 AM
Study NCT ID: NCT00937560
Status: COMPLETED
Last Update Posted: 2017-11-06
First Post: 2009-07-06
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of First Line Treatment With Avastin (Bevacizumab) in Combination With Carboplatin and Weekly Paclitaxel in Patients With Ovarian Cancer
Sponsor:
Organization: